TRKB-based signature identifies high-risk squamous cell carcinoma cases and TRKB blockade reprograms tumor and stromal cells toward suppressive phenotypes.

Bartolocci V, Capone A, Monetta R, Di Meo E, Arcano S, Valente C, Campagna D, Teson M, Mancini M, Di Lella G, Abeni D, Fania L, Ricci F, Gomes V, Scaglione GL, Mastroeni S, Candi E, Dellambra E

Open source

DOI
10.1186/s12929-026-01227-0
Published
2026 Feb 25
Container
Journal of biomedical science
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12929-026-01227-0,
  title = {TRKB-based signature identifies high-risk squamous cell carcinoma cases and TRKB blockade reprograms tumor and stromal cells toward suppressive phenotypes.},
  author = {Bartolocci V and Capone A and Monetta R and Di Meo E and Arcano S and Valente C and Campagna D and Teson M and Mancini M and Di Lella G and Abeni D and Fania L and Ricci F and Gomes V and Scaglione GL and Mastroeni S and Candi E and Dellambra E},
  year = {2026},
  journal = {Journal of biomedical science},
  doi = {10.1186/s12929-026-01227-0},
  url = {https://doi.org/10.1186/s12929-026-01227-0}
}

RIS

TY  - JOUR
TI  - TRKB-based signature identifies high-risk squamous cell carcinoma cases and TRKB blockade reprograms tumor and stromal cells toward suppressive phenotypes.
AU  - Bartolocci V
AU  - Capone A
AU  - Monetta R
AU  - Di Meo E
AU  - Arcano S
AU  - Valente C
AU  - Campagna D
AU  - Teson M
AU  - Mancini M
AU  - Di Lella G
AU  - Abeni D
AU  - Fania L
AU  - Ricci F
AU  - Gomes V
AU  - Scaglione GL
AU  - Mastroeni S
AU  - Candi E
AU  - Dellambra E
PY  - 2026
JO  - Journal of biomedical science
DO  - 10.1186/s12929-026-01227-0
UR  - https://doi.org/10.1186/s12929-026-01227-0
ER  - 

APA

V, B., A, C., R, M., E, D. M., S, A., C, V., D, C., M, T., M, M., G, D. L., D, A., L, F., F, R., V, G., GL, S., S, M., E, C., & E, D. (2026). TRKB-based signature identifies high-risk squamous cell carcinoma cases and TRKB blockade reprograms tumor and stromal cells toward suppressive phenotypes.. Journal of biomedical science. https://doi.org/10.1186/s12929-026-01227-0

Source records